Stroke risk in Australia: what the modifiable risk factors actually change

What “stroke risk” actually refers to

In Australian general practice, stroke risk is shorthand for the probability that an artery to the brain will block or burst in a defined time window. The mechanism splits two ways: roughly 80% are ischaemic (a clot blocks an artery, often a clot thrown from an irregularly beating heart or a clot forming on a plaque in a narrowed neck artery), and 20% are haemorrhagic (an artery in or around the brain bursts, most often related to long-standing high blood pressure or a weakened vessel wall).

The AIHW report on heart, stroke, and vascular disease sets out the Australian picture: around 27,000 first-ever strokes and another 11,000 recurrent strokes each year, with stroke the third leading cause of death and a leading cause of long-term disability. Outcomes have improved markedly with thrombolysis and thrombectomy for ischaemic stroke and tighter blood-pressure control for haemorrhagic stroke — but prevention before the first event is still where the largest gains live.

The single most useful concept in stroke prevention is absolute risk over five years, not a list of risk factors viewed in isolation. The Heart Foundation 2023 guideline anchored Australian general practice on a single calculator — cvdcheck.org.au — that integrates age, sex, smoking, blood pressure, total and HDL cholesterol, diabetes, atrial fibrillation, kidney function, and Aboriginal and Torres Strait Islander identification into one number.

A. Core clinical — what raises and lowers the odds

The INTERSTROKE study — a large international case-control analysis — identified ten modifiable risk factors that account for around 90% of the population attributable risk for first stroke. The Australian guidelines align with these and prioritise the highest-yield in general practice.

Risk factor	Approximate population attributable risk for first stroke	Where it’s addressed
Hypertension	≈48%	eTG Cardiovascular + Heart Foundation calculator
Physical inactivity	≈36%	AU Physical Activity Guidelines
Apolipoproteins (lipid pattern)	≈27%	Heart Foundation 2023 guideline
Diet pattern	≈23%	PREDIMED + Mediterranean evidence
Waist–hip ratio (visceral adiposity)	≈19%	RACGP weight-management resources
Psychosocial factors (stress + depression)	≈17%	Better Access Initiative
Smoking	≈12%	Quit Victoria + NPS
Cardiac causes (mostly atrial fibrillation)	≈9%	ESC AF guideline
Alcohol consumption	≈6%	NHMRC 2020 guidelines
Diabetes	≈4%	eTG Diabetes

A few of these deserve specific attention in the Australian context.

Hypertension is the largest single contributor and the most reliably treatable. Trial-confirmed reductions of around 10 mmHg systolic translate to roughly a 27% reduction in stroke risk over a few years. The SPRINT trial demonstrated that intensive blood-pressure control reduced cardiovascular events further in high-risk adults, though at some cost in side effects. AU practice individualises the target.

Atrial fibrillation raises ischaemic stroke risk approximately fivefold and is often silent — picked up on a routine pulse check, an opportunistic ECG, or by a wearable. Once identified, the CHA₂DS₂-VA score (recently updated from CHA₂DS₂-VASc) guides anticoagulation. For most adults with non-valvular atrial fibrillation and a score ≥2, a direct oral anticoagulant (apixaban, rivaroxaban, dabigatran) is preferred over aspirin or warfarin. Aspirin alone is not adequate stroke prevention in atrial fibrillation.

Smoking at least doubles ischaemic stroke risk. The risk falls quickly after stopping — much of the excess is gone within 5 years of cessation.

Diabetes raises stroke risk by approximately 1.5–2× even with reasonable glycaemic control; the larger risk reduction in trials comes from controlling blood pressure and lipids in people with diabetes, not from glycaemia alone.

Obstructive sleep apnoea is an independent modifiable risk factor and is markedly under-diagnosed in Australia, particularly in women — the Sleep Health Foundation covers the current pathway.

B. Evidence appraisal and controversies

Aspirin for primary prevention has fallen out of favour. The 2018 ASPREE, ARRIVE, and ASCEND trials showed minimal cardiovascular benefit in most adults free of established cardiovascular disease, and the bleeding harms — including intracerebral haemorrhage — were not negligible. The Australian guideline does not recommend aspirin for primary stroke prevention in most adults. Aspirin remains standard after an ischaemic stroke or TIA (secondary prevention).

Statins for primary prevention are recommended in Australian practice on the basis of calculated absolute risk — not LDL cholesterol alone. People with calculated five-year risk ≥10% benefit; some in the 5–10% range benefit when there are risk-amplifiers (family history, South Asian or Aboriginal and Torres Strait Islander ethnicity, chronic kidney disease, severe psychosocial stress). The choice and intensity follow the Heart Foundation 2023 guideline.

Carotid endarterectomy or stenting is generally reserved for symptomatic carotid stenosis ≥70% in a person who is a reasonable surgical candidate and where the centre’s perioperative stroke rate is low. Screening asymptomatic adults with carotid ultrasound is not recommended in the Heart Foundation guideline — incidental findings drive intervention without convincing benefit at population level.

Patent foramen ovale (PFO) closure is considered after a cryptogenic stroke in a younger adult (≤60 years) with no other identified cause, where the PFO has high-risk anatomy — a specialist-led decision.

Homocysteine, lipoprotein(a), high-sensitivity CRP are sometimes added to expanded “cardiovascular wellness” panels. The evidence for acting on these in primary prevention is limited. Lp(a) is genetically determined and has emerging therapies in trials but no PBS-listed treatment as of 2026; an elevated value usually shifts the threshold for starting a statin but does not yet trigger a unique therapy. Homocysteine-lowering with B-vitamins has not reduced stroke in randomised trials and is not recommended as a routine intervention.

“Cleansing” or chelation for cardiovascular prevention is not supported. The TGA regulates chelation agents tightly, and the only evidence-supported use of EDTA chelation is for heavy-metal poisoning. There is no role in primary stroke prevention.

The honest summary: the high-yield interventions are not glamorous — blood pressure, atrial fibrillation, smoking, lipids in the right people, sleep apnoea, diet pattern, movement, alcohol. The ones marketed most aggressively are not the ones with the best evidence.

C. Australian operations — what the visit actually looks like

The standard general practice stroke-risk assessment is a Heart Health Check — Medicare item 699, a long consultation specifically for cardiovascular risk assessment, available every 12 months for Australians aged 30 and over (and 18+ for Aboriginal and Torres Strait Islander people).

(MBS / PBS items verified 2026-05-15 via WebSearch — workspace egress to mbsonline.gov.au + pbs.gov.au still blocked; spot-check confirms current.)

The visit covers:

• Blood pressure (usually a clinic average plus a home or 24-hour reading if hypertension is suspected)
• Fasting lipids and glucose or HbA1c
• Urine albumin–creatinine ratio
• Pulse rhythm check (sometimes a single-lead ECG looking for atrial fibrillation)
• Weight, waist circumference
• Smoking history and offer of cessation support
• Alcohol intake screened against the NHMRC 2020 guideline
• Physical activity history
• Sleep history (including snoring, witnessed apnoeas)
• Mental-health screen if depression or chronic stress are mentioned

The calculated five-year cardiovascular risk is then discussed and a plan agreed. The Heart Foundation calculator at cvdcheck.org.au is the recommended tool.

Medication thresholds (high-level — individual prescribing is personal):

• Blood pressure-lowering is considered for adults with calculated risk ≥10% over five years, or for blood pressure ≥160/100 regardless of overall risk, or for established cardiovascular or kidney disease. First-line options per eTG and AMH are ACE inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers, and indapamide.
• Statins are considered for adults with calculated risk ≥10% over five years, or for established cardiovascular disease, or for familial hypercholesterolaemia.
• Anticoagulation in atrial fibrillation follows the CHA₂DS₂-VA score; PBS-listed direct oral anticoagulants are first-line.

For adults with established cardiovascular disease, secondary prevention is more intensive — antiplatelet therapy (typically aspirin or clopidogrel), a statin, blood-pressure-lowering, optimised glycaemic control if diabetic, and cardiac rehabilitation referral. The Stroke Foundation guidelines cover post-stroke care comprehensively.

A GP Management Plan (item 721) is appropriate when a chronic condition contributing to stroke risk — diabetes, hypertension, atrial fibrillation, sleep apnoea — is established. It opens access to subsidised allied-health visits (dietitian, exercise physiologist, psychologist) and is reviewed annually.

D. Integrative considerations

Where lifestyle and integrative interventions have an evidence base in stroke prevention, here is the honest grading.

Intervention	Effect on stroke risk	Quality of evidence
Mediterranean dietary pattern	Approximately 30% reduction in major cardiovascular events in high-risk adults	Strong (PREDIMED reanalysis)
150 minutes/week of moderate aerobic activity plus two resistance sessions (AU guideline)	Approximately 20% reduction in stroke incidence	Strong (consistent across cohorts)
Salt restriction to under 5g/day in salt-sensitive adults	Modest blood-pressure reduction (≈3 mmHg); proportional stroke risk reduction	Strong (DASH lineage trials)
Smoking cessation	Risk falls substantially within months; near-non-smoker risk within 5 years	Strong
Treating obstructive sleep apnoea (Sleep Health Foundation)	Reduction in nocturnal blood pressure; modest stroke risk reduction in adherent CPAP users	Moderate
Moderation of alcohol within NHMRC 2020 limits	Linear dose-response above 1 standard drink/day; greatest gain when cutting from heavy intake	Strong
Stress reduction (mindfulness-based stress reduction, CBT)	Small to moderate reduction in blood pressure; population-level effect on stroke unclear	Moderate
Omega-3 supplementation in non-deficient adults	No reliable effect on stroke specifically; small reduction in cardiac events at high doses (icosapent ethyl in hypertriglyceridaemia)	Moderate
Vitamin D supplementation for cardiovascular prevention	No reliable effect	Moderate (VITAL trial)
Coenzyme Q10 supplementation	No reliable effect on stroke	Weak
Garlic, hibiscus, beetroot for blood-pressure lowering	Small blood-pressure reductions; no direct stroke-outcome data	Moderate (blood pressure) / Weak (stroke)
Acupuncture for stroke prevention	No reliable effect	Weak
Acupuncture in stroke rehabilitation	Modest functional gains in some trials, not at the prevention stage	Moderate

The pattern is consistent with the rest of cardiovascular prevention: address the foundation (sleep, alcohol, dietary pattern, movement, smoking) first; supplements only correct genuine deficiency; the trial-supported prescriptions sit on top of, not instead of, the foundation.

A practical Australian order of operations:

1. Blood pressure measured properly, including at home or via 24-hour ambulatory monitoring.
2. Pulse rhythm — opportunistic atrial fibrillation check at every BP measurement, especially in adults aged 65+.
3. Fasting lipids + HbA1c.
4. Calculated five-year CVD risk using cvdcheck.org.au.
5. Smoking, alcohol, and movement history screened and addressed.
6. Sleep history screened — overnight oximetry or formal study where there is clinical suspicion of sleep apnoea.
7. Mediterranean-pattern eating and AU-guideline physical activity recommended for everyone.
8. Medications layered on top based on calculated risk and specific findings — not the other way around.

When the time window matters more than the conversation

Stroke is time-critical. The Stroke Foundation’s FAST acronym — Face drooping, Arm weakness, Speech difficulty, Time to call 000 — covers the most reliable presenting features. Other features that warrant emergency review:

• Sudden severe headache, especially if ‘thunderclap’ (peak intensity in minutes)
• Sudden loss of vision in one eye, or sudden double vision
• Sudden numbness or weakness down one side of the body
• Sudden trouble walking, severe vertigo, or loss of coordination
• Sudden confusion that has come on over minutes to an hour

Symptoms that resolve within minutes to hours are not reassuring. A transient ischaemic attack carries a high short-term risk of full stroke — up to 10% within 90 days, with most events in the first week — and warrants emergency department review the same day rather than next-week GP follow-up.

What this article is and is not

This is general health information drawn from current Australian general practice guidelines, the Stroke Foundation’s clinical resources, and large international stroke-prevention trials. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about which tests to order, whether and which medication to start, and how to interpret a calculated risk are made with your own GP, who knows your history and can examine you.

For Australian consumer-friendly summaries covering the same ground: HealthDirect, Better Health Channel, and the Stroke Foundation patient resources.

---

Sources cited

1. Stroke Foundation — Clinical Guidelines for Stroke Management
2. Heart Foundation — Australian guideline for cardiovascular disease risk (2023)
3. Australian CVD risk calculator
4. RACGP — Red Book, 10th ed.
5. Therapeutic Guidelines (eTG)
6. Australian Medicines Handbook
7. NHMRC — Australian Alcohol Guidelines 2020
8. AIHW — Heart, stroke, and vascular disease in Australia
9. HealthDirect — Stroke
10. Better Health Channel — Stroke
11. Australian Physical Activity Guidelines
12. Sleep Health Foundation — Obstructive Sleep Apnoea
13. Heart Health Check (MBS item 699)
14. Better Access Initiative
15. INTERSTROKE — global modifiable risk factors (Lancet 2016)
16. SPRINT — intensive blood pressure control (NEJM 2015)
17. PREDIMED — Mediterranean diet (NEJM 2018)
18. ESC 2024 — atrial fibrillation thromboprophylaxis
19. Stroke Foundation Australia — patient resources